Ibrutinib FDA approval date

The FDA approved Ibrutinib (Imbruvica) on 13 Nov 2013.

FDA approval date
13 Nov 2013

Drug identity checked against registry records

Also recorded as Imbruvica

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2013-11-13DayIbrutinibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA205552", "applicant_as_listed_by_fda": "PHARMACYCLICS LLC", "brand_names": ["IMBRUVICA"], "active_ingredients": ["IBRUTINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20131113", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026